Shared web leads still look inexpensive on a spreadsheet. In 2026 acquisition markets—especially Medicare and ACA—teams are finding that the cheaper record often becomes the more expensive enrollment.
Key Takeaways
- Tighter TPMO disclosure and lead-sharing expectations have made low-intent shared inventory harder to defend on persistency.
- Inbound calls and exclusive traffic typically convert more reliably because intent is demonstrated in conversation.
- Buyers are shifting benchmarks from CPL to outcome metrics such as cost per qualified opportunity and longer-term persistency.
What’s Changing in Lead Economics
CMS marketing and TPMO-related updates in recent cycles tightened how leads can be marketed, disclosed, and shared. The practical effect: multi-sold comparison leads that once looked efficient now show weaker buyer quality and weaker retention profiles.
That does not mean every call channel is automatically efficient. Qualification rules, transfer timing, and sales capacity still determine whether call volume becomes revenue.
What Performance Teams Should Measure
- Qualified-call rate against explicit eligibility and intent criteria.
- Sales disposition quality—not only connect rate.
- Persistency-aware CPA where chargebacks or early attrition matter.
Zaidi Consulting Group builds healthcare performance marketing around high-intent acquisition: proprietary traffic, conversion systems, and pre-qualified call delivery designed for measurable sales opportunities—not vanity lead volume.
Sources & References
- CMS Medicare Communications and Marketing Guidelines and TPMO disclosure/lead-sharing updates.
- 2026 insurance lead-cost and Medicare acquisition benchmark analyses comparing shared, exclusive, and call channels.
- Industry call-conversion research showing stronger outcomes for answered marketing conversations versus passive form fills.